SomaLogic, Inc.
Industrials · Services-Commercial Physical & Biological Research · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | |
|---|---|---|---|
| Revenue | $97.7M | $81.6M | $55.9M |
| Operating income | −$175.8M | −$73.3M | −$34.4M |
| Net income | −$109.2M | −$87.5M | −$53.0M |
| Total assets | $647.4M | $706.1M | $242.3M |
| Total liabilities | $84.8M | $94.1M | $56.4M |
| Equity | $562.6M | $612.0M | $185.9M |
| EPS (diluted) | $-0.59 | $-0.64 | $-0.81 |
| Shares out. | 182.1M | 181.2M | 114.3M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- −180.0%
- Net margin
- −111.8%
- Return on equity
- −19.4%
- Return on assets
- −16.9%
- Return on capital (ROCE)
- −29.1%
- Liabilities / assets
- 13.1%
- Debt / equity
- 0.15×
- Book value / share
- $3.09
- Revenue growth (YoY)
- 19.7%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Altman Z″ (distress)
- 7.53safe
- Accruals / assets
- −1.3%clean
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 3 warning● 4 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 18, 2021
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Ark Investment Management LlcPassive (13G)Jan 10, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Taich AdamOfficer — Interim CEO | Jan 5, 2024 | D | 48,425 | — |
| Roelke Alison MarieOfficer — Chief People Officer | Jan 5, 2024 | D | 17,143 | — |
| Post Richard ADirector | Jan 5, 2024 | D | 57,430 | — |
| Casdin EliDirector | Jan 5, 2024 | D | 3,430 | — |
| Margulies Anne H.Director | Jan 5, 2024 | D | 23,430 | — |
| Gutierrez RubenOfficer — General Counsel | Jan 5, 2024 | D | 21,027 | — |
| Cox TroyDirector | Jan 5, 2024 | D | 78,430 | — |
| Margulies Anne H.Director | Jan 5, 2024 | D | 3,430 | — |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Shareholder voteJan 5, 2024
- Regulation FD disclosureJan 2, 2024
- Regulation FD disclosureDec 29, 2023
- Regulation FD disclosureDec 29, 2023
- Regulation FD disclosureDec 26, 2023
- Regulation FD disclosureDec 26, 2023
- Regulation FD disclosure · Other material eventDec 21, 2023
- Director / officer changeDec 12, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SCHEDULE 13G/AJan 10, 2025
- SC 13G/AJan 29, 2024
- SC 13G/AJan 29, 2024
- 15-12GJan 16, 2024
- EFFECTJan 11, 2024
- EFFECTJan 11, 2024
- 4FORM 4 SUBMISSIONJan 9, 2024
- 4FORM 4 SUBMISSIONJan 9, 2024
- 4FORM 4 SUBMISSIONJan 9, 2024
- 4FORM 4 SUBMISSIONJan 9, 2024
- 4FORM 4 SUBMISSIONJan 9, 2024
- 4FORM 4 SUBMISSIONJan 9, 2024
- 4FORM 4 SUBMISSIONJan 9, 2024
- 4FORM 4 SUBMISSIONJan 9, 2024
- 4FORM 4 SUBMISSIONJan 9, 2024
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.